Report #2837650

Received Apr 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: IL
Recovered: Unknown
Vaccinated: —
Onset: Feb 1, 2025
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	Y011819	OT / LA

Symptoms (4)

FatigueFlushingHeadacheParaesthesia

Symptom narrative

FLUSHING; FATIGUE; TINGLING; HEADACHE; This spontaneous report was received from a regulatory authority, CDC Wonder on 22-Apr-202, referring to a 59-year-old male patient. The patient's medical history included allergy to sulfa. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date (reported as 27-Feb-2025, conflicting information), the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (lot #Y011819, expiration date: 01-Oct-2025), administered by intramuscular route in left arm as prophylaxis. On 01-Feb-2025, the patient experienced fatigue, tingling, flushing and headache. At the reporting time, the outcome of the events was unknown. The action taken with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was reported as not applicable. The causal relationship between the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was unknown.

Medical history

Medical History/Concurrent Conditions: Sulfonamide allergy